Understanding complexity in the HIF signaling pathway using systems biology and mathematical modeling

Hypoxia is a common micro-environmental stress which is experienced by cells during a range of physiologic and pathophysiologic processes. The identification of the hypoxia-inducible factor (HIF) as the master regulator of the transcriptional response to hypoxia transformed our understanding of the mechanism underpinning the hypoxic response at the molecular level and identified HIF as a potentially important new therapeutic target. It has recently become clear that multiple levels of regulatory control exert influence on the HIF pathway giving the response a complex and dynamic activity profile. These include positive and negative feedback loops within the HIF pathway as well as multiple levels of crosstalk with other signaling pathways. The emerging model reflects a multi-level regulatory network that affects multiple aspects of the physiologic response to hypoxia including proliferation, apoptosis, and differentiation. Understanding the interplay between the molecular mechanisms involved in the dynamic regulation of the HIF pathway at a systems level is critically important in defining new appropriate therapeutic targets for human diseases including ischemia, cancer, and chronic inflammation. Here, we review our current knowledge of the regulatory circuits which exert influence over the HIF response and give examples of in silico model-based predictions of the dynamic behaviour of this system.

[1]  L. Bingle,et al.  In vitro study of HIF‐1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI‐3K/Akt and MEK1/ERK pathways , 2005, The Journal of pathology.

[2]  Murtaza M Tambuwala,et al.  A dynamic model of the hypoxia-inducible factor 1&agr; (HIF-1&agr;) network , 2013, Journal of Cell Science.

[3]  F. Pileur Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) ‐dependent signaling , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  G. Parati,et al.  Circulating factors are involved in hypoxia-induced hepcidin suppression. , 2014, Blood cells, molecules & diseases.

[5]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[6]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[7]  David A. Simpson,et al.  MicroRNA-155 Promotes Resolution of Hypoxia-Inducible Factor 1α Activity during Prolonged Hypoxia , 2011, Molecular and Cellular Biology.

[8]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[9]  G. Semenza,et al.  HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. , 2007, Cancer cell.

[10]  G. Semenza Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease , 2001, Pediatric Research.

[11]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[12]  N. Kosaka,et al.  Micromanaging Iron Homeostasis , 2012, The Journal of Biological Chemistry.

[13]  S. Rocha,et al.  Evolutionary Conserved Regulation of HIF-1β by NF-κB , 2011, PLoS genetics.

[14]  W. Friedrichs,et al.  Stabilization of HIF-2alpha through redox regulation of mTORC2 activation and initiation of mRNA translation , 2012, Oncogene.

[15]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[16]  E. Hafen,et al.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.

[17]  E. Kohmura,et al.  MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells , 2013, Journal of Neuro-Oncology.

[18]  A. Tee,et al.  Hypoxia-inducible Factor 1α Is Regulated by the Mammalian Target of Rapamycin (mTOR) via an mTOR Signaling Motif* , 2007, Journal of Biological Chemistry.

[19]  M. You,et al.  Bnip3 Mediates the Hypoxia-induced Inhibition on Mammalian Target of Rapamycin by Interacting with Rheb* , 2007, Journal of Biological Chemistry.

[20]  Yuichi Makino,et al.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.

[21]  J. Nielsen,et al.  Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Semenza,et al.  Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. , 1993, Blood.

[23]  S. Rocha,et al.  Regulation of hypoxia-inducible factor-1α by NF-κB , 2008, The Biochemical journal.

[24]  J. Pouysségur,et al.  Activation of HIF‐1α in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway , 2009, Journal of cellular physiology.

[25]  Frédéric Dayan,et al.  The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. , 2011, Cancer research.

[26]  S. Conway Morris Darwin's dilemma: the realities of the Cambrian ‘explosion’ , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[27]  B. Kholodenko,et al.  Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. , 2000, European journal of biochemistry.

[28]  C. Schofield,et al.  Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. , 2002, The Biochemical journal.

[29]  KojiMaemura,et al.  Endothelial PAS Domain Protein 1 Gene Promotes Angiogenesis Through the Transactivation of Both Vascular Endothelial Growth Factor and Its Receptor, Flt-1 , 2004 .

[30]  P. Puigserver,et al.  A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1α Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like , 2011, Molecular and Cellular Biology.

[31]  Roland H Wenger,et al.  Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.

[32]  M. Simon Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization. , 2006, Advances in experimental medicine and biology.

[33]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[34]  G. Lahav,et al.  Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.

[35]  C. Peyssonnaux,et al.  Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis , 2012, Haematologica.

[36]  J. Barrett,et al.  HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. , 2004, The EMBO journal.

[37]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[38]  B. Kholodenko,et al.  Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling device , 2015, Cell cycle.

[39]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[40]  A. Howe,et al.  Negative regulation of HIF‐1α by an FBW7‐mediated degradation pathway during hypoxia , 2011, Journal of cellular biochemistry.

[41]  E. Cummins,et al.  Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. , 2009, Antioxidants & redox signaling.

[42]  Lai Wei,et al.  Negative Regulation of Hif1a Expression and TH17 Differentiation by Hypoxia Regulated miR-210 , 2014, Nature Immunology.

[43]  E. Debnam,et al.  Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression , 2005, Gut.

[44]  B. Weber,et al.  miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer , 2008, Cancer biology & therapy.

[45]  P. Jaakkola,et al.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.

[46]  K. Kivirikko,et al.  Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.

[47]  J. Houštěk,et al.  The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. , 2013, Biochimica et biophysica acta.

[48]  J. McClung,et al.  Hepcidin: A Critical Regulator of Iron Metabolism during Hypoxia , 2011, Advances in hematology.

[49]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[50]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1 , 2007, Molecular and Cellular Biology.

[51]  G. Panayotou,et al.  Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1α* , 2006, Journal of Biological Chemistry.

[52]  C. Brinckerhoff,et al.  Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel–Lindau renal cell carcinoma , 2005, Oncogene.

[53]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[54]  A. Cheong,et al.  Regulation of IL-1β–induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways , 2013, Proceedings of the National Academy of Sciences.

[55]  J. Nielsen,et al.  Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity , 2006, Proceedings of the National Academy of Sciences.

[56]  B. Kholodenko Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[57]  R. Denton,et al.  Dissociation of the eukaryotic initiation factor‐4E/4E‐BP1 complex involves phosphorylation of 4E‐BP1 by an mTOR‐associated kinase , 1999, FEBS letters.

[58]  J. Pouysségur,et al.  p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1* , 1999, The Journal of Biological Chemistry.

[59]  T. Kietzmann,et al.  Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[60]  S. Antonarakis,et al.  Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Xianglin Shi,et al.  Vanadate-induced Expression of Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor through Phosphatidylinositol 3-Kinase/Akt Pathway and Reactive Oxygen Species* , 2002, The Journal of Biological Chemistry.

[62]  W. Kolch,et al.  Basic fibroblast growth factor modifies the hypoxic response of human bone marrow stromal cells by ERK-mediated enhancement of HIF-1α activity. , 2014, Stem cell research.

[63]  S. Rocha,et al.  HIF-1α restricts NF-κB-dependent gene expression to control innate immunity signals , 2014, Disease Models & Mechanisms.

[64]  Walter Kolch,et al.  When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling , 2013, Cell Communication and Signaling.

[65]  Thilo Hagen,et al.  Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α , 2003, Science.

[66]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.

[67]  Lan K. Nguyen,et al.  Regulation of oscillation dynamics in biochemical systems with dual negative feedback loops , 2012, Journal of The Royal Society Interface.

[68]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[69]  E. Dimova,et al.  The MAPK Pathway and HIF‐1 Are Involved in the Induction of the Human PAI‐1 Gene Expression by Insulin in the Human Hepatoma Cell Line HepG2 , 2006, Annals of the New York Academy of Sciences.

[70]  L. Poellinger,et al.  Transcriptional Up-regulation of Inhibitory PAS Domain Protein Gene Expression by Hypoxia-inducible Factor 1 (HIF-1) , 2007, Journal of Biological Chemistry.

[71]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[72]  Dong-Hoon Shin,et al.  A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1α , 2008, Molecular Cancer Therapeutics.

[73]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[74]  Eyal Gottlieb,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[75]  M. Cole,et al.  Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells. , 2012, Cancer Research.

[76]  Xudong Dai,et al.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT , 2009, Cell cycle.

[77]  P. Lambin,et al.  The mTOR target 4E‐BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency , 2008, Proteomics.

[78]  M. Blagosklonny,et al.  The purpose of the HIF-1/PHD feedback loop: To limit mTOR-induced HIF-1α , 2011, Cell cycle.

[79]  P. Ratcliffe,et al.  The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. , 2004, Advances in enzyme regulation.

[80]  J. Pouysségur,et al.  HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.

[81]  Yuichi Makino,et al.  Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3α Locus* , 2002, The Journal of Biological Chemistry.

[82]  J. S. Weng,et al.  Hypoxia-Inducible Factor 1 Regulation through Cross Talk between mTOR and MT1-MMP , 2013, Molecular and Cellular Biology.

[83]  B. Kholodenko,et al.  The dynamic control of signal transduction networks in cancer cells , 2015, Nature Reviews Cancer.

[84]  E. Ciszak,et al.  Phosphorylation of serine 264 impedes active site accessibility in the E1 component of the human pyruvate dehydrogenase multienzyme complex. , 2007, Biochemistry.

[85]  M. Celeste Simon,et al.  Multiple Factors Affecting Cellular Redox Status and Energy Metabolism Modulate Hypoxia-Inducible Factor Prolyl Hydroxylase Activity In Vivo and In Vitro , 2006, Molecular and Cellular Biology.

[86]  A. Cheong,et al.  Hypoxia-inducible factor (HIF) network: insights from mathematical models , 2013, Cell Communication and Signaling.

[87]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[88]  L. Reed,et al.  Alpha-keto acid dehydrogenase complexes. X. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[89]  V. Sée,et al.  Tight Control of Hypoxia-inducible Factor-α Transient Dynamics Is Essential for Cell Survival in Hypoxia , 2014, The Journal of Biological Chemistry.

[90]  Yan Tang,et al.  NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. , 2002, Experimental hematology.

[91]  N. Chandel,et al.  Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[92]  Christine C. Hudson,et al.  Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin , 2002, Molecular and Cellular Biology.

[93]  William M. Gallagher,et al.  An Intact Canonical NF-κB Pathway Is Required for Inflammatory Gene Expression in Response to Hypoxia , 2011, The Journal of Immunology.

[94]  Hirotomo TanakaTakashi,et al.  MicroRNA-183 upregulates HIF-1a by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells , 2013 .

[95]  T. Resink,et al.  Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) ‐dependent signaling , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[96]  Christian Sillaber,et al.  BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin. , 2002, Blood.

[97]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[98]  M. Simon Mitochondrial Reactive Oxygen Species are Required for Hypoxic HIFα Stabilization , 2006 .

[99]  J. Remacle,et al.  HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR. , 1999, Biochemical and biophysical research communications.

[100]  T. Kietzmann,et al.  Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .

[101]  E. Paraskeva,et al.  Atypical CRM1-dependent Nuclear Export Signal Mediates Regulation of Hypoxia-inducible Factor-1α by MAPK* , 2008, Journal of Biological Chemistry.

[102]  J. Gutkind,et al.  The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. , 2000, Cancer research.

[103]  S. Schreiber,et al.  Control of p70 S6 kinase by kinase activity of FRAP in vivo , 1995, Nature.

[104]  Wei Xu,et al.  Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway , 2014, Autophagy.

[105]  N. Oldham,et al.  Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. , 2005, Molecular bioSystems.

[106]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[107]  L. Huang,et al.  HIF‐1α induces cell cycle arrest by functionally counteracting Myc , 2004 .

[108]  G. Semenza,et al.  Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[109]  D. Mottet,et al.  ERK activation upon hypoxia: involvement in HIF‐1 activation , 2000, FEBS letters.

[110]  Michael Q. Zhang,et al.  An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia , 2009, Nucleic acids research.

[111]  M. Dewhirst,et al.  NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment , 2010, Proceedings of the National Academy of Sciences.